1-13 of 13
Deborah Doss
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

Clinical Trials & Observations
Paul G. Richardson, David Siegel, Rachid Baz, Susan L. Kelley, Nikhil C. Munshi, Jacob Laubach, Daniel Sullivan, Melissa Alsina, Robert Schlossman, Irene M. Ghobrial, Deborah Doss, Nora Loughney, Laura McBride, Elizabeth Bilotti, Palka Anand, Lisa Nardelli, Sandra Wear, Gail Larkins, Min Chen, Mohamad H. Zaki, Christian Jacques, Kenneth C. Anderson
Journal: Blood
Blood (2013) 121 (11): 1961–1967.
https://doi.org/10.1182/blood-2012-08-450742
Published: 2013
Journal Articles

A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or In Combination with Low-Dose Dexamethasone In Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib

Paul G Richardson, MD, David Siegel, MD, PhD, Rachid Baz, MD, Susan L. Kelley, MD, Nikhil C. Munshi, MD, Daniel Sullivan, MD, Melissa Alsina, MD, Deborah Doss, RN, OCN, Laura McBride, Gail Larkins, RN, Maria Lizza, BS, Xin Yu, Mohamed Zaki, MD, Christian J. Jacques, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2010) 116 (21): 864.
https://doi.org/10.1182/blood.V116.21.864.864
Published: 2010
Journal Articles

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Paul G. Richardson, Edie Weller, Sagar Lonial, Andrzej J. Jakubowiak, Sundar Jagannath, Noopur S. Raje, David E. Avigan, Wanling Xie, Irene M. Ghobrial, Robert L. Schlossman, Amitabha Mazumder, Nikhil C. Munshi, David H. Vesole, Robin Joyce, Jonathan L. Kaufman, Deborah Doss, Diane L. Warren, Laura E. Lunde, Sarah Kaster, Carol DeLaney, Teru Hideshima, Constantine S. Mitsiades, Robert Knight, Dixie-Lee Esseltine, Kenneth C. Anderson
Journal: Blood
Blood (2010) 116 (5): 679–686.
https://doi.org/10.1182/blood-2010-02-268862
Published: 2010
Journal Articles

High Response Rates and Encouraging Time-to-Event Data with Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Final Results of a Phase I/II Study.

Paul G Richardson, Sagar Lonial, Andrzej J Jakubowiak, Sundar Jagannath, Noopur S Raje, David E Avigan, Irene Ghobrial, Robert L Schlossman, Amitabha Mazumder, Nikhil C. Munshi, Jacob Laubach, David Vesole, Robin Joyce, Jacalyn Rosenblatt, Wanling Xie, Deborah Doss, Diane L. Warren, Kate Ittleman, Carolyn Revta, Dixil Francis, Charles Leister, Sarah Kaster, Carol Delaney, Marisa Lauria, Constantine S. Mitsiades, Teru Hideshima, Robert Knight, Dixie-Lee Esseltine, Edie Weller, Kenneth C. Anderson
Journal: Blood
Blood (2009) 114 (22): 1218.
https://doi.org/10.1182/blood.V114.22.1218.1218
Published: 2009
Journal Articles

A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or in Combination with Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib.

Paul Richardson, David Siegel, Rachid Baz, Susan L. Kelley, Nikhil C. Munshi, Daniel Sullivan, Laura McBride, Deborah Doss, Gail Larkins, Christian Jacques, Arlene Donaldson, Kenneth C. Anderson
Journal: Blood
Blood (2009) 114 (22): 301.
https://doi.org/10.1182/blood.V114.22.301.301
Published: 2009
Journal Articles

Lenalidomide, Bortezomib, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Encouraging Efficacy in High Risk Groups with Updated Results of a Phase I/II Study

Paul Richardson, MD, Sagar Lonial, MD, Andrzej Jakubowiak, MD, PhD, Sundar Jagannath, MD, Noopur S Raje, MD, David Avigan, MD, Irene M Ghobrial, MD, Robert L Schlossman, MD, Amitabha Mazumder, MD, Nikhil C Munshi, MD, David H Vesole, MD, PhD, Robin Joyce, MD, Deborah Doss, RN, OCN, Diane L Warren, BS, Stephen W Hayes, Sarah Kaster, BS, Carol Delaney, BSN, Marisa Lauria, BA, Constantine Mitsiades, MD, PhD, Teru Hideshima, MD, PhD, Robert D. Knight, MD, Dixie-Lee Esseltine, MD, Kenneth C Anderson, MD
Journal: Blood
Blood (2008) 112 (11): 92.
https://doi.org/10.1182/blood.V112.11.92.92
Published: 2008
Journal Articles

Lenalidomide, Bortezomib, and Dexamethasone (Rev/Vel/Dex) as Front-Line Therapy for Patients with Multiple Myeloma (MM): Preliminary Results of a Phase 1/2 Study.

Paul Richardson, Sundar Jagannath, Noopur Raje, Andrzej Jakubowiak, Sagar Lonial, David Avigan, Irene Ghobrial, Robert Schlossman, Amitabha Mazumder, Nikhil Munshi, Robin Joyce, Deborah Doss, Diane Warren, Stephen Hayes, Lawrence Giove, S. Kaster, Carol Delaney, Marisa Lauria, Constantine Mitsiades, Teru Hideshima, Robert Knight, Dixie-Lee Esseltine, Kenneth Anderson
Journal: Blood
Blood (2007) 110 (11): 187.
https://doi.org/10.1182/blood.V110.11.187.187
Published: 2007
Journal Articles

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

Clinical Trials & Observations
Paul G. Richardson, Emily Blood, Constantine S. Mitsiades, Sundar Jagannath, Steven R. Zeldenrust, Melissa Alsina, Robert L. Schlossman, S. Vincent Rajkumar, K. Raman Desikan, Teru Hideshima, Nikhil C. Munshi, Kathleen Kelly-Colson, Deborah Doss, Mary L. McKenney, Svetlana Gorelik, Diane Warren, Andrea Freeman, Rebecca Rich, Anfang Wu, Marta Olesnyckyj, Kenton Wride, William S. Dalton, Jerome Zeldis, Robert Knight, Edie Weller, Kenneth C. Anderson
Journal: Blood
Blood (2006) 108 (10): 3458–3464.
https://doi.org/10.1182/blood-2006-04-015909
Published: 2006
Journal Articles

Safety and Activity of KOS-953 in Patients with Relapsed Refractory Multiple Myeloma (MM): Interim Results of a Phase 1 Trial.

Paul G. Richardson, MD, Asher A. Chanan-Khan, MD, Melissa Alsina, MD, Deborah Doss, R.N., Beverly Landrigan, R.N., Dawn Kettner, N.P., Maher Albitar, MD, Constantine Mitsiades, MD, Gillian F. Cropp, MS, Robert G. Johnson, MD, Alison L. Hannah, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2005) 106 (11): 361.
https://doi.org/10.1182/blood.V106.11.361.361
Published: 2005
Journal Articles

Phase II Trial of Single Agent Bortezomib (VELCADE®) in Patients with Previously Untreated Multiple Myeloma (MM).

Paul G. Richardson, Asher Chanan-Khan, Robert L. Schlossman, Nikhil C. Munshi, Patrick Wen, Hannah Briemberg, David Kuter, Anne-Louise Oaklander, Sagar Lonial, Hani Hassoun, Deborah Doss, Kathleen Colson, Mary McKenney, Karen Hande, Alexandra Koryzna, Barbara Stoklas, Laura Lunde, Svetlana Gorelik, Cliona McAlister, Andrea Freeman, Diane Warren, Denise Collins, Dixie Esseltine, Anthony Amato, Kenneth C. Anderson
Journal: Blood
Blood (2004) 104 (11): 336.
https://doi.org/10.1182/blood.V104.11.336.336
Published: 2004
Journal Articles

Phase I Clinical Trial of Oral Administration of the Histone Deacetylase (HDAC) Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Relapsed/Refractory Multiple Myeloma (MM).

Paul Richardson, MD, Robert L. Schlossman, MD, Constantine S. Mitsiades, MD, PhD, Nikhil C. Munshi, MD, Kathleen Colson, Deborah Doss, Mary McKenney, Karen Hande, Svetlana Gorelik, Laura Lunde, Anna Stepanek, Andrea Freeman, Karyn Dinand, Stephen Hayes, Reggie Michelle, Keith Doucet, Diane Warren, Nicholas Mitsiades, MD, PhD, Victoria M. Richon, PhD, Judi Chiao, MD, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2004) 104 (11): 1503.
https://doi.org/10.1182/blood.V104.11.1503.1503
Published: 2004
Journal Articles

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

Clinical Trials & Observations
Paul G. Richardson, Robert L. Schlossman, Edie Weller, Teru Hideshima, Constantine Mitsiades, Faith Davies, Richard LeBlanc, Laurence P. Catley, Deborah Doss, Kathleen Kelly, Mary McKenney, Julie Mechlowicz, Andrea Freeman, Reggie Deocampo, Rebecca Rich, Joan J. Ryoo, Dharminder Chauhan, Kathe Balinski, Jerome Zeldis, Kenneth C. Anderson
Journal: Blood
Blood (2002) 100 (9): 3063–3067.
https://doi.org/10.1182/blood-2002-03-0996
Published: 2002
Journal Articles

T-cell–depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect

Clinical Trials & Observations
Edwin Alyea, Edie Weller, Robert Schlossman, Christine Canning, Iain Webb, Deborah Doss, Peter Mauch, Karen Marcus, David Fisher, Andrea Freeman, Bijal Parikh, John Gribben, Robert Soiffer, Jerome Ritz, Kenneth Anderson
Journal: Blood
Blood (2001) 98 (4): 934–939.
https://doi.org/10.1182/blood.V98.4.934
Published: 2001